Participants
Contact
The results of a study on the mitochondrial protein Mitofusin-2 by Antonio Zorzano’s team have been echoed in local, national and international media.
Through this new study on Mitofusin-2 published in Embo Journal, Zorzano and his lab reveal that this protein is also an essential component for the general health of the cell.
Read the article in Gaceta Médica (PDF)
Link to the IRB news article
In other media:
eSciencenews (PDF)
EurekaAlert (PDF)
Physorg (PDF)
ScienceCodex (PDF)
Sciencedaily.com (PDF)
Agencia SINC (PDF)
Innovations Report (PDF)
Tendencias21 (PDF)
Proteomics (PDF)
MedicalNewsToday - popular news (PDF)
The Freepress Journal (PDF)
Zeenews.india.com (PDF)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
